Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — September 2025

Genmab — September 2025

Planlagt Fastgjort Låst Flyttet Genmab
283 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • royalR Offline
    royalR Offline
    royal
    wrote on sidst redigeret af
    #183

    Håber du tager fejl. 🙂

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #184

      it does put some additional perspective on why some early clinical trials were deemed not good enough to proceed

      1 Reply Last reply
      0
      • nohopeN Offline
        nohopeN Offline
        nohope
        wrote on sidst redigeret af
        #185

        Vil undre mig meget hvis det ikke koster dyrt på kursen.

        1 Reply Last reply
        0
        • L Offline
          L Offline
          lahn1
          wrote on sidst redigeret af
          #186

          Yes EL that was rettidigt omhu, as we say kn Denmark.

          1 Reply Last reply
          0
          • L Offline
            L Offline
            lahn1
            wrote on sidst redigeret af
            #187

            It sures raises some attention to Gmab with this size of M&A. And with the very succesfull Profound deal in the bag, hopefully market will trust Gmab judgement this time.

            1 Reply Last reply
            0
            • B Offline
              B Offline
              BuyLow
              wrote on sidst redigeret af
              #188

              The offices of Merus and Genmab are next to each other in Utrecht. They know each other well. GMAB has 3Bn cash, earning 1Bn a year, rising to 1,5Bn per year
              in 2028. They can easily fund the debt based on recurring cashflow.

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #189

                they are actually in the same building...

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #190

                  14/10 09:24
                  af E L
                  The new building next to the (also rather new...) Genmab R&D Center in Utrecht was opened. it will house Genmab, Merus and ImmunoPrecise Antibodies https://vastgoedberichten.nl/2023/10/13/kadans-opent-innovatiecentrum-accelerator-utrecht-op-utrecht-science-park/

                  1 Reply Last reply
                  0
                  • L Offline
                    L Offline
                    lahn1
                    wrote on sidst redigeret af
                    #191

                    Have we heard anything from the IPA collaboration ?

                    1 Reply Last reply
                    0
                    • L Offline
                      L Offline
                      lahn1
                      wrote on sidst redigeret af
                      #192

                      Markedet er meget uenige om

                      1 Reply Last reply
                      0
                      • SolsenS Offline
                        SolsenS Offline
                        Solsen
                        wrote on sidst redigeret af
                        #193

                        Det bør koste på kursen pga af størrelsen af købet.

                        1 Reply Last reply
                        0
                        • SolsenS Offline
                          SolsenS Offline
                          Solsen
                          wrote on sidst redigeret af
                          #194

                          Genmab skal for første gang gældsætte sig eller sælge aktier for at finansiere købet.

                          1 Reply Last reply
                          0
                          • nohopeN Offline
                            nohopeN Offline
                            nohope
                            wrote on sidst redigeret af
                            #195

                            I bedste fald er udbytte eller tilbagekøb udskudt mindst 5 år.

                            1 Reply Last reply
                            0
                            • T Offline
                              T Offline
                              transalp
                              wrote on sidst redigeret af
                              #196

                              Men tror vi på genmab, er det jo mere menig i udvidelse, snare end udbytte og tilbagekøb. Men giver en lille trækning, når man tænker på fabrikken i USA..

                              1 Reply Last reply
                              0
                              • L Offline
                                L Offline
                                lahn1
                                wrote on sidst redigeret af
                                #197

                                @buylow, ja de kommer hurtigt ned på et acceptabelt gældsniveau som de selv siger mindre end 3 i 2027. Darzalex royalties lægger en sikker bund og øger troværdigheden af tilbagebetalingen af lånet.

                                1 Reply Last reply
                                0
                                • nohopeN Offline
                                  nohopeN Offline
                                  nohope
                                  wrote on sidst redigeret af
                                  #198

                                  Tror vi på Jan? Ham der sagde at vi ville få ret i voldgifterne ? Ham der ville forklare JnJ at de skulle købe SuperDara ?

                                  1 Reply Last reply
                                  0
                                  • L Offline
                                    L Offline
                                    lahn1
                                    wrote on sidst redigeret af
                                    #199

                                    @transalp, med Profound bio frisk i mente og Gmabs evne til at se guldet før andre, kan vi jo håbe at de igen har snuppet en usleben diamond for næsten af de store drenge i klassen.

                                    1 Reply Last reply
                                    0
                                    • T Offline
                                      T Offline
                                      transalp
                                      wrote on sidst redigeret af
                                      #200

                                      Yes lahn1. Det lydervikk som det er et "ukendt" firma, for dem..

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        ProinvestorNEWS
                                        wrote on sidst redigeret af
                                        #201

                                        Genmab: "Fornuftig køb til høj pris https://proinvestor.com/boards/128617

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #202

                                          Merus CEO: We’re really optimistic about the potential for our drug in head and neck cancer https://www.youtube.com/watch?v=4UBXaksMRAQ

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper